Status:
COMPLETED
Study Evaluating Venlafaxine Extended Release in Elderly Depressed Patients
Lead Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Conditions:
Depressive Syndrome
Anxiety
Eligibility:
All Genders
60+ years
Brief Summary
In this study we will assess as a primary objective the effect of venlafaxine retard treatment on primary care attended elderly patients with depressive syndrome. We will also study secondarily its ef...
Eligibility Criteria
Inclusion
- Patients older than 60 years
- Depressive syndrome with associated anxiety symptoms, according to a symptoms intensity HAM-D17³14
Exclusion
- Participation in other studies in the last 3 months before the start of the study
- Known hypersensibility to venlafaxine
- Clinically significant abnormalities according to the venlafaxine labeling
Key Trial Info
Start Date :
July 1 2004
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2005
Estimated Enrollment :
59 Patients enrolled
Trial Details
Trial ID
NCT00247429
Start Date
July 1 2004
End Date
October 1 2005
Last Update
September 1 2009
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.